MET and head and neck squamous cell carcinoma: While autocrine HGF activation of c-Met has been reported in other cancer types, HNSCC cells fail to secrete detectable levels of the ligand, indicating the TAF supplied HGF activates c-Met in a predominantly paracrine manner [23,34].